| Members |
targetComponentId |
| Netilmicin 10mg/mL injection solution 1.5mL ampule (product) |
Product containing precisely netilmicin (as netilmicin sulfate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Netilmicin 100mg/mL injection solution 1mL ampule (product) |
Product containing precisely netilmicin (as netilmicin sulfate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Netilmicin 100mg/mL injection solution 1.5mL ampule (product) |
Product containing precisely netilmicin (as netilmicin sulfate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Netilmicin 100mg/mL injection solution 2mL ampule (product) |
Product containing precisely netilmicin (as netilmicin sulfate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Netilmicin 50mg/mL injection solution 1mL ampule (product) |
Netilmicin (as netilmicin sulfate) 50 mg/mL solution for injection |
| Neuritis AND/OR radiculitis due to displacement of lumbar intervertebral disc |
Neuritis due to displacement of lumbar intervertebral disc |
| Neuritis AND/OR radiculitis due to displacement of lumbar intervertebral disc |
Radiculitis due to displacement of lumbar intervertebral disc (disorder) |
| Family history observation (situation) |
antécédents familiaux |
| Family history observation (situation) |
Family history of clinical finding |
| Obtains consultation from the appropriate health care providers (procedure) |
consultation |
| obésité selon l'âge d'apparition |
Obesity (disorder) |
| occlusion endoscopique unilatérale d'une trompe utérine |
Endoscopic occlusion of left fallopian tube |
| occlusion endoscopique unilatérale d'une trompe utérine |
Endoscopic occlusion of right fallopian tube |
| occlusion unilatérale d'une trompe utérine |
Occlusion of right fallopian tube |
| occlusion unilatérale d'une trompe utérine |
Occlusion of left fallopian tube |
| Omeprazole 40mg powder and solvent for injection solution vial (product) |
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Omeprazole 40mg powder for infusion solution vial (product) |
Product containing precisely omeprazole (as omeprazole sodium) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ondansetron 2mg/mL injection solution 2mL ampule (product) |
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection |
| Ondansetron 2mg/mL injection solution 4mL ampule (product) |
Ondansetron (as ondansetron hydrochloride) 2 mg/mL solution for injection |
| Benzoic and salicylic acid ointment (substance) |
Salicylic acid (substance) |
| Benzoic and salicylic acid ointment (substance) |
Benzoic acid (substance) |
| orientation terminée |
Referral placed (situation) |
| Poliomyelitis osteopathy of the pelvic region and/or thigh (disorder) |
Poliomyelitis osteopathy of pelvis and femur |
| Unilateral earache |
Otalgia of left ear (finding) |
| Unilateral earache |
Otalgia of right ear |
| Unilateral excision of ovary (situation) |
Right oophorectomy |
| Unilateral excision of ovary (situation) |
Left oophorectomy |
| p |
Tumor staging descriptor p (tumor staging) |
| p.m. trough specimen (specimen) |
p.m. trough specimen (qualifier value) |
| pH observations |
pH - finding |
| Palivizumab 100mg powder and solvent for injection solution vial (product) |
Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Palivizumab 50mg powder and solvent for injection solution vial (product) |
Palivizumab 50 mg powder for solution for injection vial |
| Pipothiazine palmitate 50mg/mL injection solution 1mL ampule (product) |
Pipothiazine palmitate 50 mg/mL solution for injection |
| Pipothiazine palmitate 50mg/mL injection solution 2mL ampule (product) |
Pipothiazine palmitate 50 mg/mL solution for injection |
| Disodium pamidronate 15mg powder and solvent for infusion vial (product) |
Product containing precisely disodium pamidronate 15 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Disodium pamidronate 30mg powder and solvent for infusion vial (product) |
Disodium pamidronate 30 mg powder for solution for injection vial |
| Disodium pamidronate 90mg powder and solvent for infusion vial (product) |
Disodium pamidronate 90 mg powder for solution for injection vial |
| Peritoneal dialysis route (qualifier value) |
Peritoneal dialysis technique (qualifier value) |
| par le circuit d'hémodialyse |
Hemodialysis technique (qualifier value) |
| No medical history (situation) |
No history of clinical finding in subject (situation) |
| patient porteur d'un appareil auditif |
Does use hearing aid |
| peau - mole bénigne et nævus |
papillome cutané |
| peau - mole bénigne et nævus |
Epidermal nevus (disorder) |
| Benign pemphigus |
pemphigus bénin familial |
| Benign pemphigus |
Pemphigus |
| pemphigus mineur |
pemphigus vulgaire oral |
| Hit by aircraft, without accident to aircraft, occupant of spacecraft injured (event) |
Hit by aircraft, without accident to aircraft (event) |
| percuté par un bateau en faisant du ski nautique, docker ou ouvrier portuaire blessé |
Hit by boat whilst water skiing |
| percuté par un bateau en faisant du ski nautique, nageur blessé |
Hit by boat whilst water skiing |
| Hit by boat while water skiing, occupant of small powered boat injured (event) |
Hit by boat whilst water skiing |
| Hit by boat while water skiing, occupant of small unpowered boat injured |
Hit by boat whilst water skiing |
| Hit by boat while water skiing, water skier injured |
Hit by boat whilst water skiing |
| Relative killed |
Family member deceased (situation) |
| Unilateral hearing loss |
Hearing loss of left ear (disorder) |
| Unilateral hearing loss |
Hearing loss of right ear (disorder) |
| Phlegmonous stomatitis AND cellulitis |
Stomatitis |
| Phlegmonous stomatitis AND cellulitis |
cellulite |
| Phlebitis of central nervous system venous sinuses |
Phlebitis of intracranial venous sinus |
| Phlebitis and thrombophlebitis of intracranial sinuses |
Thrombophlebitis of intracranial venous sinus |
| Codeine phosphate 60mg/mL injection solution 1mL ampule (product) |
Codeine phosphate 60 mg/mL solution for injection |
| Phenobarbital sodium 200mg/mL injection solution 1mL ampule (product) |
Product containing precisely phenobarbital sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Product containing sodium phenylbutyrate (medicinal product) |
Product containing phenylbutyric acid (medicinal product) |
| Phenytoin sodium 50mg/mL injection solution 5mL ampule (product) |
Phenytoin sodium 50 mg/mL solution for injection |
| Substance with piperazine structure (substance) |
Piperazine derivative |
| Open wound of finger without complication |
Open wound of finger |
| Open wound of knee and/or leg and/or ankle (disorder) |
plaie ouverte d'un membre inférieur (trouble) |
| Open wound of knee and/or leg and/or ankle (disorder) |
Open wound of lower leg |
| Open wound of knee and/or leg and/or ankle (disorder) |
plaie ouverte d'un genou |
| Open wound of knee and/or leg and/or ankle (disorder) |
Open wound of ankle |
| Learning disabilities health action plan declined (procedure) |
procédure administrative liée à une incapacité |
| Learning disabilities health action plan declined (procedure) |
Finding related to care planning (finding) |
| pleurs permanents du nourrisson |
Family difficulty with crying infant |
| pleurs permanents du nourrisson |
Constantly crying infant (finding) |
| Tuberculous pneumonia of humans (disorder) |
Tuberculous pneumonia |
| poids anormal par rapport à la norme de croissance ou à l'âge |
Body weight abnormal for age (finding) |
| Target weight (observable entity) |
Target body weight |
| Polycystic kidney disease, adult type |
Autosomal dominant polycystic kidney disease (disorder) |
| Polyneuropathy associated with type II diabetes mellitus (disorder) |
Polyneuropathy due to type 2 diabetes mellitus |
| Ointment (substance) |
Ointment |
| Effervescent oral powder |
Effervescent powder for oral suspension |
| Effervescent oral powder |
Effervescent powder for oral solution |
| Rubella live vaccine powder and solvent for injection solution vial (product) |
Vaccine product containing Rubella virus antigen (medicinal product) |
| Injection powder |
poudre pour suspension injectable |
| Injection powder |
Powder for solution for injection |
| Congenital/genetic syndrome with poikiloderma (disorder) |
Hereditary sclerosing poikiloderma |
| Prednisolone methylsulfobenzoate |
Prednisolone metasulfobenzoate sodium (substance) |
| prescription d'un médicament |
Medicinal prescription record |
| prescription d'un médicament |
prescription de médicaments |
| prescription médicamenteuse arrêtée : fin de l'essai clinique |
Drug treatment stopped at end of clinical trial (situation) |
| Parent relationship problem |
problèmes relationnels |
| procaryote |
Domain Bacteria |
| procaryote |
domaine : Archée |
| Urinary catheter appliance procedures |
intervention associée à une sonde vésicale |
| Carries emergency treatment (procedure) |
Carries emergency treatment (finding) |
| Unidentified chemical, agent or biological agent, assumed toxic (substance) |
substance toxique |
| Product containing erythropoietin (medicinal product) |
Erythropoietin receptor agonist-containing product |
| Miscellaneous products |
produit pharmaceutique ou biologique |
| Progesterone 50mg/mL injection solution 1mL ampule (product) |
Progesterone 50 mg/mL solution for injection |
| Progesterone 50mg/mL injection solution 2mL ampule (product) |
Progesterone 50 mg/mL solution for injection |
| prophylaxie diététique |
Dietary regime (regime/therapy) |
| protamine et/ou composé de protamine |
Protamine and/or protamine derivative (substance) |
FHIR